DNA damage response inhibitors enhance tumour treating fields (TTFields) potency in glioma stem-like cells

por Vanderlinden, Aurelie, Jones, Callum G., Myers, Katie N., Rominiyi, Ola, Collis, Spencer J.
Publicado 2023

Tumour treating fields therapy for glioblastoma: current advances and future directions

por Rominiyi, Ola, Vanderlinden, Aurelie, Clenton, Susan Jane, Bridgewater, Caroline, Al-Tamimi, Yahia, Collis, Spencer James
Publicado 2020

Correction: Tumour treating fields therapy for glioblastoma: current advances and future directions

por Rominiyi, Ola, Vanderlinden, Aurelie, Clenton, Susan Jane, Bridgewater, Caroline, Al-Tamimi, Yahia, Collis, Spencer James
Publicado 2021

Identification and Validation of ERK5 as a DNA Damage Modulating Drug Target in Glioblastoma

por Carmell, Natasha, Rominiyi, Ola, Myers, Katie N., McGarrity-Cottrell, Connor, Vanderlinden, Aurelie, Lad, Nikita, Perroux-David, Eva, El-Khamisy, Sherif F., Fernando, Malee, Finegan, Katherine G., Brown, Stephen, Collis, Spencer J.
Publicado 2021